Absence of long-term changes in urine biomarkers after AKI: findings from the CRIC study
McCoy I, Hsu J, Bonventre J, Parikh C, Go A, Liu K, Ricardo A, Srivastava A, Cohen D, He J, Chen J, Rao P, Muiru A, Hsu C. Absence of long-term changes in urine biomarkers after AKI: findings from the CRIC study. BMC Nephrology 2022, 23: 311. PMID: 36100915, PMCID: PMC9472364, DOI: 10.1186/s12882-022-02937-x.Peer-Reviewed Original ResearchConceptsChronic Renal Insufficiency CohortUrine biomarkersMCP-1/CrKIM-1/CrCKD progressionNon-AKI groupChronic Renal Insufficiency Cohort StudyEffect of AKIPre-hospital characteristicsUrine protein/creatinine ratioBanked urine samplesCohort of adultsProtein/creatinine ratioProgressive CKDStudy visitsAKICKDUrineUrine samplesAKI hospitalizationsAlbumin/CrLong-term changesNon-AKI hospitalizationsPre-hospitalBiomarkersThe association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis
Kanbay M, Copur S, Siriopol D, Yildiz A, Berkkan M, Popa R, Hasbal N, Ortiz A, Perazella M. The association between acute kidney injury and outcomes in cancer patients receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis. Clinical Kidney Journal 2022, 16: 817-826. PMID: 37151409, PMCID: PMC10157786, DOI: 10.1093/ckj/sfac194.Peer-Reviewed Original ResearchAcute kidney injuryImmune checkpoint inhibitorsEffect of AKICheckpoint inhibitorsCancer patientsKidney injuryDevelopment of AKISystematic reviewImmune checkpoint inhibitor therapySevere acute kidney injuryPersistent kidney dysfunctionSevere AKI patientsCheckpoint inhibitor therapyRisk of deathNon-randomized studiesCochrane Library databasesRisk of mortalityNovel therapeutic approachesWeb of ScienceAKI patientsICPI treatmentCause mortalityInhibitor therapyKidney dysfunctionMortality outcomes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply